Royalty Pharma Buys Dicerna's Royalty Interest In OXLUMO

Royalty Pharma plc (RPRX) has acquired Dicerna Pharmaceuticals Inc.'s (DRNA) royalty interest in OXLUMO or lumasiran for an upfront cash payment of $180 million and up to $60 million in contingent sales-based milestone payments.

OXLUMO, which has been approved by the U.S. Food and Drug Administration and European Medicines Agency for the treatment of primary hyperoxaluria type 1, is marketed by Alnylam Pharmaceuticals Inc.

Dicerna is entitled to royalties in the mid to high single digits based on OXLUMO global net sales.

Dicerna said that it expects the transaction, together with its cash, cash equivalents, held-to-maturity investments and anticipated milestone and other payments from existing collaborations, to extend its projected cash runway and be sufficient to fund the execution of its current clinical and operating plan into 2024.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Twitter has rolled out the tipping feature called "Tips" for everyone around the globe using the microblogging site with more payment options to choose from, including cryptocurrencies such as Bitcoin. This is a new way for people to receive and show support on Twitter with money. The feature is currently available on iOS and will be available on Android over the coming weeks. Amazon.com has launched weekly Max-Your-Vax Sweepstakes to encourage their employees to get vaccinated against COVID-19. The sweepstakes began on August 6, 2021 and ends on October 21, 2021, with six draws during the sweepstakes period for 18 prizes worth nearly $2 million, including cash prizes, new vehicle or cash and vacation plus 40 hours of Paid Time Off. Target Corp. announced its plans to hire 100,000 seasonal team members at its stores across the country for this holiday shopping season, though fewer than previous years. With this, the company aims to invest in more flexible scheduling, training, pay and benefits for its existing team members. In a statement, the company said it is also offering around 5 million more hours to its existing staff.
Follow RTT